Mersana Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Mersana Therapeutics, Inc. has filed 704 SEC EDGAR filings since 12 Aug 2008

SEC filing history

Showing 151-175 of 702 matching filings.

Per page
25
Current page
7
4

OWNERSHIP DOCUMENT

Filing date
12 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90033

SC 13G

Filing date
17 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-271766

EFFECT filing

Filing date
09 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271766

424B5

Filing date
09 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38129

ARS

Filing date
26 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38129

DEFA14A

Filing date
26 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38129

SCHEDULE 14A

Filing date
26 Apr 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271766

424B5

Filing date
28 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-271766

POS AM

Filing date
28 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-271766

POSASR

Filing date
28 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

OWNERSHIP DOCUMENT

Filing date
16 Feb 2024
Reporting date
13 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90033

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90033

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90033

AMENDMENT NO. 1

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90033

MERSANA THERAPEUTICS, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .